Title |
Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease
|
---|---|
Published in |
Clinical and Experimental Gastroenterology, December 2014
|
DOI | 10.2147/ceg.s27530 |
Pubmed ID | |
Authors |
Yezaz A Ghouri, David M Richards, Erik F Rahimi, Joseph T Krill, Katherine A Jelinek, Andrew W DuPont |
Abstract |
Probiotics are microorganisms that are ingested either in combination or as a single organism in an effort to normalize intestinal microbiota and potentially improve intestinal barrier function. Recent evidence has suggested that inflammatory bowel disease (IBD) may result from an inappropriate immunologic response to intestinal bacteria and a disruption in the balance of the gastrointestinal microbiota in genetically susceptible individuals. Prebiotics, synbiotics, and probiotics have all been studied with growing interest as adjuncts to standard therapies for IBD. In general, probiotics have been shown to be well-tolerated with few side effects, making them a potential attractive treatment option in the management of IBD. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Finland | 2 | 40% |
Spain | 1 | 20% |
Unknown | 2 | 40% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 60% |
Practitioners (doctors, other healthcare professionals) | 1 | 20% |
Scientists | 1 | 20% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 3 | <1% |
Canada | 2 | <1% |
United Kingdom | 1 | <1% |
Germany | 1 | <1% |
Belarus | 1 | <1% |
Australia | 1 | <1% |
Unknown | 468 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 75 | 16% |
Student > Bachelor | 75 | 16% |
Researcher | 69 | 14% |
Student > Ph. D. Student | 55 | 12% |
Other | 35 | 7% |
Other | 82 | 17% |
Unknown | 86 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 123 | 26% |
Agricultural and Biological Sciences | 66 | 14% |
Nursing and Health Professions | 46 | 10% |
Biochemistry, Genetics and Molecular Biology | 40 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 30 | 6% |
Other | 61 | 13% |
Unknown | 111 | 23% |